Bron Gebbiena M, Smith Susan R, Williamson Judy D, Tripp Daniel W, Rocke Tonie E
University of Wisconsin, School of Veterinary Medicine, Department of Pathobiological Sciences, 1656 Linden Drive, Madison, Wisconsin 53706, USA.
US Geological Survey National Wildlife Health Center, 6006 Schroeder Road, Madison, Wisconsin 53711, USA.
J Wildl Dis. 2021 Jul 1;57(3):632-636. doi: 10.7589/JWD-D-20-00122.
The variable response of wild mice to Yersinia pestis infection, the causative agent of plague, has generated much speculation concerning their role in the ecology of this potentially lethal disease. Researchers have questioned the means by which Y. pestis is maintained in nature and also sought methods for managing the disease. Here we assessed the efficacy of a new tool, the sylvatic plague vaccine (SPV), in wild-caught northern grasshopper mice (Onychomys leucogaster) and commercially acquired Sonoran deer mice (Peromyscus maniculatus sonoriensis). More than 40% of the animals survived a subcutaneous Y. pestis challenge of 175,000 colony forming units (over 30,000 times the white mouse 50% lethal dose) in both vaccine-treated and control groups. Our results indicate that SPV distribution is unlikely to protect adult mice from plague infection in field settings and corroborate the heterogeneous response to Y. pestis infection in mice reported by others.
野生小鼠对鼠疫耶尔森菌(鼠疫的病原体)感染的反应各异,这引发了人们对其在这种潜在致命疾病生态中所起作用的诸多猜测。研究人员对鼠疫耶尔森菌在自然界中的维持方式提出了疑问,并寻求管理该疾病的方法。在此,我们评估了一种新工具——森林鼠疫疫苗(SPV),对野生捕获的北方草甸小鼠(白腹林鼠)和商业购买的索诺拉鹿鼠的效果。在疫苗处理组和对照组中,超过40%的动物在皮下接种175,000个菌落形成单位的鼠疫耶尔森菌(超过小白鼠半数致死剂量的30,000倍)后存活下来。我们的结果表明,在野外环境中,SPV的分发不太可能保护成年小鼠免受鼠疫感染,并证实了其他人所报道的小鼠对鼠疫耶尔森菌感染的异质性反应。